Effects of evening vs morning levothyroxine intake: A randomized double-blind crossover trial

Archives of Internal Medicine

Volumn 170, Issue 22, 2010, Pages 1996-2003

  Bolk, Nienke ^a   Visser, Theo J ^b   Nijman, Judy ^a   Jongste, Ineke J ^a   Tijssen, Jan G P ^c   Berghout, Arie ^a  

^a Maasstad Hospital Rotterdam   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; LEVOTHYROXINE SODIUM; LIOTHYRONINE; LIPID; PLACEBO; THYRAX DUOTAB; THYROID HORMONE; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BEDTIME DOSAGE; BODY MASS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSSOVER PROCEDURE; DOSAGE SCHEDULE COMPARISON; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EVENING DOSAGE; FEMALE; HEALTH SURVEY; HEART RATE; HUMAN; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; NETHERLANDS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGED; BODY MASS INDEX; CREATININE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART RATE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOTHYROIDISM; LIPIDS; MALE; MIDDLE AGED; NETHERLANDS; QUALITY OF LIFE; QUESTIONNAIRES; THYROID HORMONES; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 78650126223     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2010.436     Document Type: Article

References (38)

1. Tunbridge WM, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham Survey. Clin Endocrinol (Oxf). 1977;7(6):481-493. (Pubitemid 8235965)
2. 4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489-499.
3. Wenzel KW, Kirschsieper HE. Aspects of the absorption of oral L-thyroxine in normal man. Metabolism. 1977;26(1):1-8. (Pubitemid 8027634)
4. Sherman SI, Tielens ET, Ladenson PW. Sucralfate causes malabsorption of L-thyroxine. Am J Med. 1994;96(6):531-535.
5. Liel Y, Harman-Boehm I, Shany S. Evidence for a clinically important adverse effect of fiber-enriched diet on the bioavailability of levothyroxine in adult hypothyroid patients. J Clin Endocrinol Metab. 1996;81(2):857-859. (Pubitemid 26055713)
6. Benvenga S, Bartolone L, Pappalardo MA, et al. Altered intestinal absorption of L-thyroxine caused by coffee. Thyroid. 2008;18(3):293-301. (Pubitemid 351415797)
7. Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of levothyroxine. JAMA. 2000;283(21):2822-2825. (Pubitemid 30387827)
8. Sachmechi I, Reich DM, Aninyei M, Wibowo F, Gupta G, Kim PJ. Effect of proton pump inhibitors on serum thyroid-stimulating hormone level in euthyroid patients treated with levothyroxine for hypothyroidism. Endocr Pract. 2007;13(4):345-349.
9. Campbell NR, Hasinoff BB, Stalts H, Rao B, Wong NC. Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism. Ann Intern Med. 1992;117(12):1010-1013.
10. Siraj ES, Gupta MK, Reddy SS. Raloxifene causing malabsorption of levothyroxine. Arch Intern Med. 2003;163(11):1367-1370.
11. Bolk N, Visser TJ, Kalsbeek A, van Domburg RT, Berghout A. Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients. Clin Endocrinol (Oxf ). 2007;66(1):43-48. (Pubitemid 44952493)
12. Esposito S, Prange AJ Jr, Golden RN. The thyroid axis and mood disorders: overview and future prospects. Psychopharmacol Bull. 1997;33(2):205-217. (Pubitemid 27293109)
13. Duyff RF, Van den Bosch J, Laman DM, van Loon BJ, Linssen WH. Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study. J Neurol Neurosurg Psychiatry. 2000;68(6):750-755. (Pubitemid 30265276)
14. Tielens ET, Pillay M, Storm C, Berghout A. Changes in cardiac function at rest before and after treatment in primary hypothyroidism. Am J Cardiol. 2000;85(3):376-380. (Pubitemid 30052914)
15. den Hollander JG, Wulkan RW, Mantel MJ, Berghout A. Correlation between severity of thyroid dysfunction and renal function. Clin Endocrinol (Oxf ). 2005;62(4):423-427. (Pubitemid 40503368)
16. Friis T, Pedersen LR. Serum lipids in hyper- and hypothyroidism before and after treatment. Clin Chim Acta. 1987;162(2):155-163. (Pubitemid 17022580)
17. Cappola AR, Ladenson PW. Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab. 2003;88(6):2438-2444.
18. Van der Zee KI, Sanderman S. Het Meten van de Algemene Gezondheidstoestand met de RAND-36: een Handleiding [Measurement of General Health With the RAND-36: AManual]. Groningen, the Netherlands: Noorderlijk Centrum voor Gezondheidsvraagstukken, Rijks Universiteit Groningen; 1993.
19. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67(6):361-370.
20. Smets EM, Garssen B, Bonke B, De Haes JC. The Multidimensional Fatigue Inventory (MFI): psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39(3):315-325.
21. Lazarus JH, Hall R, Othman S, et al. The clinical spectrum of postpartum thyroid disease. QJM. 1996;89(6):429-435. (Pubitemid 26184328)
22. Kenward MG, Rao CR, Rao DC, eds. Design and analysis of cross-over trials. In: Handbook of Statistics. 2nd ed. Amsterdam, the Netherlands: Elsevier Science; 2008:464-490.
23. Wilson P, Perdikis G, Hinder RA, Redmond EJ, Anselmino M, Quigley EM. Prolonged ambulatory antroduodenal manometry in humans. Am J Gastroenterol. 1994;89(9):1489-1495. (Pubitemid 24313039)
24. Moore JG, Englert E Jr. Circadian rhythm of gastric acid secretion in man. Nature. 1970;226(5252):1261-1262.
25. Centanni M, Gargano L, Canettieri G, et al. Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med. 2006;354(17):1787-1795.
26. Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R, Dayan CM. Psychological well-being in patients on "adequate" doses of L-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol (Oxf ). 2002;57(5):577-585.
27. Wekking EM, Appelhof BC, Fliers E, et al. Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism. Eur J Endocrinol. 2005;153(6):747-753. (Pubitemid 43020224)
28. Hamilton TE, Davis S, Onstad L, Kopecky KJ. Thyrotropin levels in a population with no clinical, autoantibody, or ultrasonographic evidence of thyroid disease: implications for the diagnosis of subclinical hypothyroidism. J Clin Endocrinol Metab. 2008;93(4):1224-1230. (Pubitemid 351519714)
29. Hoogwerf BJ, Nuttall FQ. Long-term weight regulation in treated hyperthyroid and hypothyroid subjects. Am J Med. 1984;76(6):963-970. (Pubitemid 14120399)
30. Appelhof BC, Fliers E, Wekking EM, et al. Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial. J Clin Endocrinol Metab. 2005;90(5):2666-2674. (Pubitemid 40686307)
31. Escobar-Morreale HF, Obregón MJ, Escobar del Rey F, Morreale de Escobar G. Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats. J Clin Invest. 1995;96(6):2828-2838.
32. Roos A, Linn-Rasker SP, van Domburg RT, Tijssen JP, Berghout A. The starting dose of levothyroxine in primary hypothyroidism treatment: a prospective, randomized, double-blind trial. Arch Intern Med. 2005;165(15):1714-1720. (Pubitemid 41138957)
33. Scanlan TS. Minireview: 3-iodothyronamine (T1AM): a new player on the thyroid endocrine team? Endocrinology. 2009;150(3):1108-1111.
34. Vonk R, van der Schot AC, Kahn RS, Nolen WA, Drexhage HA. Is autoimmune thyroiditis part of the genetic vulnerability (or an endophenotype) for bipolar disorder? Biol Psychiatry. 2007;62(2):135-140.
35. Elliott DP. Effect of levothyroxine administration time on serum TSH in elderly patients. Ann Pharmacother. 2001;35(5):529-532. (Pubitemid 32428124)
36. Bach-Huynh TG, Nayak B, Loh J, Soldin S, Jonklaas J. Timing of levothyroxine administration affects serum thyrotropin concentration. J Clin Endocrinol Metab. 2009;94(10):3905-3912.
37. Woeber KA. Update on the management of hyperthyroidism and hypothyroidism. Arch Intern Med. 2000;160(8):1067-1071.
38. Singer PA, Cooper DS, Levy EG, et al; Standards of Care Committee, American Thyroid Association. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA. 1995;273(10):808-812.